ViaDerma, Inc. (OTCMKTS:VDRM) Short Interest Up 1,287.5% in December

ViaDerma, Inc. (OTCMKTS:VDRM) was the recipient of a large growth in short interest in December. As of December 15th, there was short interest totalling 11,100 shares, a growth of 1,287.5% from the November 30th total of 800 shares. Based on an average trading volume of 3,981,600 shares, the short-interest ratio is presently 0.0 days.

ViaDerma Stock Down 3.7 %

VDRM traded down $0.00 during trading on Thursday, hitting $0.01. 420,499 shares of the stock traded hands, compared to its average volume of 1,735,952. The business has a 50 day moving average price of $0.01 and a 200 day moving average price of $0.01. ViaDerma has a twelve month low of $0.00 and a twelve month high of $0.02.

ViaDerma Company Profile

ViaDerma, Inc operates as a specialty pharmaceutical company in the United States. It focuses on developing and marketing pharmaceutical products, as well as licensing its technology to companies in the pharmaceutical industry in various therapeutic areas. The company’s lead product is Vitastem, a tetracycline-based topical antibiotic used for cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries.